Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney Foundation

Am J Kidney Dis. 1995 Jan;25(1):107-12. doi: 10.1016/0272-6386(95)90636-3.


All individuals with diabetes mellitus should be screened yearly with a spot urine albumin:creatinine ratio to identify those who are at increased risk for the development of complications of diabetes mellitus, including nephropathy, retinopathy, and cardiovascular disease. Once these high-risk individuals are appropriately identified, it is recommended that therapy with an angiotensin-converting enzyme (ACE) inhibitor be initiated. In addition, cardiovascular risk factors should be investigated, and when appropriate, therapeutic interventions should be initiated according to existing recommendations.

Publication types

  • Guideline
  • Practice Guideline

MeSH terms

  • Albuminuria / diagnosis*
  • Albuminuria / etiology
  • Albuminuria / therapy*
  • Decision Trees
  • Diabetes Complications*
  • Diabetic Nephropathies / diagnosis
  • Foundations
  • Humans
  • Mass Screening*
  • Nephrology
  • Risk Factors
  • United States